Fate Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
Go back to Fate Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.15 +0.06 (2.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.09 | 52 Week High | $4.76 | |||
| Open | $2.07 | 52 Week Low | $1.46 | |||
| Day High | $2.23 | P/E | N/A | |||
| Day Low | $2.01 | EPS | $-1.91 | |||
| Volume | 5,698,136 | |||||
